[1] |
Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS,2009,23(4):525-530.
|
[2] |
Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness[J]. Bull World Health Organ,2001,79(3):208-213.
|
[3] |
Duggan J, Walls HM. Ocular complications of cryptococcal meningitis in patients with HIV: report of two cases and review of the literature[J]. J Int Assoc Physicians AIDS Care (Chic),2012,11(5):283-288.
|
[4] |
Rex JH, Larsen RA, Dismukes WE, et al. Catastrophic visual loss due to Cryptococcus neoformans meningitis[J]. Medicine (Baltimore),1993,72(4):207-224.
|
[5] |
Moodley A, Rae W, Bhigjee A. Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved[J]. South Afr J HIV Med,2015,16(1):1-9.
|
[6] |
Portelinha J, Passarinho MP, Almeida AC, et al. Bilateral optic neuropathy associated with cryptococcal meningitis in an immunocompetent patient[J]. BMJ Case Rep,2014,2014.
|
[7] |
Fessler RD, Sobel J, Guyot L, et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis[J]. J Acquir Immune Defic Syndr Hum Retrovirol,1998,17(2):137-142.
|
[8] |
中华医学会感染病学分会艾滋病学组. 艾滋病诊疗指南第三版(2015版)[J]. 中华临床感染病杂志,2015,8(5):385-400.
|
[9] |
Bratton EW, El Husseini N, Chastain CA, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant[J]. PLoS One,2012,7(8):e43582.
|
[10] |
Heyderman RS, Gangaidzo IT, Hakim JG, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe[J]. Clin Infect Dis,1998,26(2):284-289.
|
[11] |
Loyse A, Wainwright H, Jarvis JN, et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure[J]. AIDS,2010,24(3):405-410.
|
[12] |
Govender N, Meintjes G, Bicanic T, et al. Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update[J]. S Afr J HIV Med,2013,14(2):76-86.
|
[13] |
Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis,2010,50(3):291-322.
|
[14] |
Rolfes MA, Hullsiek KH, Rhein J, et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis[J]. Clin Infect Dis,2014,59(11):1607-1614.
|
[15] |
Macsween KF, Bicanic T, Brouwer AE, et al. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review[J]. J Infect,2005,51(4):e221-224.
|
[16] |
Jiang PF, Yu HM, Zhou BL, et al. The role of an Ommaya reservoir in the management of children with cryptococcal meningitis[J]. Clin Neurol Neurosurg,2010,112(2):157-159.
|
[17] |
陈明泉, 施光峰, 秦刚, 等. 隐球菌脑膜炎146例临床分析[J]. 中华传染病杂志,2007,25(4):199-202.
|
[18] |
Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis[J]. J Neurosurg,2016,125(1):177-186.
|
[19] |
Liu L, Zhang R, Tang Y, et al. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus[J]. Biosci Trends,2014,8(6):327-332.
|
[20] |
Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients[J]. Clin Infect Dis,2003,37(5):673-678.
|
[21] |
Liliang PC, Liang CL, Chang WN, et al. Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus[J]. Clin Infect Dis,2002,34(12):E64-E68.
|
[22] |
Yadav YR, Parihar V, Sinha M. Lumbar peritoneal shunt[J]. Neurol India,2010,58(2):179-184.
|
[23] |
Miyake H. Shunt Devices for the Treatment of Adult Hydrocephalus: Recent Progress and Characteristics[J]. Neurol Med Chir (Tokyo),2016,56(5):274-283.
|
[24] |
Alkherayf F, Abou Al-Shaar H, Awad M. Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience[J]. Clin Neurol Neurosurg,2015,136:5-9.
|
[25] |
Kazui H, Miyajima M, Mori E, et al. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial[J]. Lancet Neurol,2015,14(6):585-594.
|
[26] |
曹杨, 王清河, 冯恩山, 等. 腰大池腹腔分流术治疗艾滋病并发新型隐球菌性脑膜炎所致非脑积水性高颅压12例分析[J]. 疑难病杂志,2015,14(12):1225-1227.
|
[27] |
胡志亮, 魏洪霞, 池云, 等. 两性霉素B三天加量疗法在艾滋病并隐球菌性脑膜炎中的应用[J]. 中华临床感染病杂志,2014,7(4):319-323.
|
[28] |
Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension[J]. Expert Rev Neurother,2015,15(8):851-856.
|
[29] |
Newton PN, Thai le H, Tip NQ, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis[J]. Clin Infect Dis,2002,35(6):769-772.
|
[30] |
Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev,2015(9):CD004405.
|
[31] |
Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis[J]. Cochrane Database Syst Rev,2016,4:CD002244.
|
[32] |
Beardsley J, Wolbers M, Kibengo FM, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis[J]. N Engl J Med,2016,374(6):542-554.
|
[33] |
Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis[J]. N Engl J Med,2013,368(14):1291-1302.
|
[34] |
Johanson CE, Duncan JA, 3rd, Klinge PM, et al. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease[J]. Cerebrospinal Fluid Res,2008,5:10.
|
[35] |
Meda J, Kalluvya S, Downs JA, et al. Cryptococcal meningitis management in Tanzania with strict schedule of serial lumber punctures using intravenous tubing sets: an operational research study[J]. J Acquir Immune Defic Syndr,2014,66(2):e31-e36.
|